Grace Therapeutics, Inc. Shares Outstanding (Cover Page)
Grace Therapeutics, Inc. (GRCE) had Shares Outstanding (Cover Page) of 21.04 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 21.04M shares.
- 2026-06-15: Entity Common Stock, Shares Outstanding 16.27M shares.
- 2026-02-12: Entity Common Stock, Shares Outstanding 15.47M shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 15.47M shares; Entity Common Stock, Shares Outstanding as first filed 14.13M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-08-11 | 21.04M shares 10-Q · filed 2026-08-13 | |
| 2026-06-15 | 16.27M shares 10-K · filed 2026-06-18 | |
| 2026-02-12 | 15.47M shares 10-Q · filed 2026-02-12 | |
| 2025-11-13 | 15.47M shares 10-Q/A · filed 2025-11-17 | 14.13M shares 10-Q · filed 2025-11-13 |
| 2025-08-11 | 13.83M shares 10-Q · filed 2025-08-12 | |
| 2025-06-19 | 13.83M shares 10-K · filed 2025-06-23 | |
| 2025-02-12 | 13.42M shares 10-Q/A · filed 2025-02-19 | 10.14M shares 10-Q · filed 2025-02-13 |
| 2024-11-13 | 10.14M shares 10-Q · filed 2024-11-13 | |
| 2024-08-08 | 10.14M shares 10-Q · filed 2024-08-09 | |
| 2024-06-21 | 9.40M shares 10-K · filed 2024-06-21 | |
| 2024-02-09 | 9.40M shares 10-Q · filed 2024-02-12 | |
| 2023-11-09 | 9.40M shares 10-Q · filed 2023-11-13 | |
| 2023-08-09 | 7.45M shares 10-Q · filed 2023-08-11 | |
| 2023-06-23 | 44.61M shares 10-K · filed 2023-06-23 | |
| 2023-02-13 | 44.61M shares 10-Q · filed 2023-02-14 | |
| 2022-11-14 | 44.61M shares 10-Q · filed 2022-11-14 | |
| 2022-08-11 | 44.49M shares 10-Q · filed 2022-08-11 | |
| 2022-07-29 | 44.49M shares 10-K/A · filed 2022-07-29 | |
| 2022-06-21 | 44.44M shares 10-K · filed 2022-06-21 | |
| 2022-02-14 | 44.29M shares 10-Q · filed 2022-02-14 | |
| 2021-11-10 | 44.29M shares 10-Q · filed 2021-11-10 | |
| 2021-08-12 | 208.38M shares 10-Q · filed 2021-08-12 | |
| 2021-06-22 | 208.38M shares 10-K · filed 2021-06-22 | |
| 2021-02-09 | 179.50M shares 10-Q · filed 2021-02-09 | |
| 2020-11-16 | 96.89M shares 10-Q · filed 2020-11-16 | |
| 2020-08-13 | 96.89M shares 10-Q · filed 2020-08-13 | |
| 2020-06-26 | 92.49M shares 10-K · filed 2020-06-29 | |
| 2019-03-31 | 78.13M shares 20-F · filed 2019-06-26 | |
| 2018-03-31 | 25.64M shares 20-F · filed 2018-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |